Lam Research Corporation Announces Financial Results for the Quarter Ended September 27, 2009
More News related to LRCX
- StockPreacher.com Issues Trading Overview for Aixtron Aktiengesellschaft
- Lam Research Corporation Announces Participation at Credit Suisse Annual Technology Conference
- Caris & Co Upgrades Lam Research (LRCX) to Above Average
- Lam Research Corporation Announces Financial Results for the Quarter Ended September 27, 2009
- Trading Radar for 10/21: Boeing (BA), eBay (EBAY), Wells Fargo (WFC), US Bancorp (USB), Eli Lilly (ELY), St. Jude Medical (STJ) Report
More News related to Press Releases
- Canaccord Adams Maintains a 'Buy' on Protalix BioTherapeutics (PLX); Cerezyme Supply on Track, See More Uplyso EAP Uptake
- Bove Says US Banking System, Dollar to Benefit from Dubai Crisis
- Broadpoint.AmTech Says Solar Inventory Getting Healthier into Year-end
- UBS Maintains a Neutral rating on American Eagle Outfitters (AEO); Lowers Estimates Through 2011
- Barclays Reiterates an 'Overweight' on Deere (DE); Adjusts Estimates & PT
FREMONT, Calif.--(BUSINESS WIRE)-- Lam Research Corporation (NASDAQ: LRCX) highlights for the September 2009 quarter were:
(in thousands, except per share data and percentages) Revenue: $ 318,548 Operating Margin: U.S. GAAP: 9.2 % Ongoing: 2.5 % Net Income: U.S. GAAP: $ 16,797 Ongoing: $ 4,181 Diluted EPS: U.S. GAAP: $ 0.13 Ongoing: $ 0.03
Lam Research Corporation today announced financial results for the quarter ended September 27, 2009. Revenue for the period was $318.5 million, gross margin was $136.8 million and net income was $16.8 million, or $0.13 per diluted share, compared to revenue of $217.8 million, gross margin of $67.8 million and net loss of $(88.5) million, or $(0.70) per diluted share, for the June 2009 quarter. Shipments for the September 2009 quarter were $355 million compared to $246 million during the June 2009 quarter.
The Company's ongoing results for the September 2009 quarter exclude certain costs for previously announced restructuring activities and the finalization of a portion of certain liabilities for Internal Revenue Code Section 409A related expenses. The Company's ongoing results for the June 2009 quarter excluded certain costs for previously announced restructuring activities and asset impairments, a legal judgment, a non-cash goodwill impairment charge, certain one-time contract termination costs, a net tax expense for valuation allowance, net tax expense on resolution of certain tax matters, and interest and legal fees related to Internal Revenue Code Section 409A tax expenses. Management uses the presentation of ongoing gross margin, ongoing operating expenses, ongoing operating income (loss), ongoing operating margin, ongoing net income (loss), and ongoing net income (loss) per diluted share to evaluate the Company's operating and financial results. The Company believes the presentation of ongoing results is useful to investors for analyzing business trends and comparing performance to prior periods, along with enhancing the investor's ability to view the Company's results from management's perspective. A table presenting a reconciliation of ongoing results to results under U.S. GAAP is included at the end of this press release and on the Company's web site.
Ongoing net income was $4.2 million, or $0.03 per diluted share in the September 2009 quarter compared to ongoing net loss of $(57.0) million, or $(0.45) per diluted share, for the June 2009 quarter. Ongoing gross margin for the September 2009 quarter was $131.3 million or 41.2%, compared to ongoing gross margin of $67.8 million, or 31.1%, for the June 2009 quarter. The sequential increase in gross margin was primarily due to improved factory and field utilization as a result of increased business volume and a more favorable product mix. Ongoing operating expenses for the September 2009 quarter increased to $123.3 million compared with the June 2009 quarter of $114.3 million. This increase was primarily the result of one-time credits against spending realized in the June 2009 quarter, planned additional spending on R&D programs and additional employee variable compensation as a result of higher profit levels.
The geographic distribution of shipments and revenue during the September 2009 quarter is shown in the following table:
Region Shipments Revenue North America 10 % 9 % Europe 6 % 7 % Japan 18 % 18 % Korea 24 % 23 % Taiwan 31 % 29 % Asia Pacific 11 % 14 %
Cash and cash equivalents, short-term investments and restricted cash and investments balances were $761.2 million at the end of the September 2009 quarter, compared to $757.8 million at the end of the June 2009 quarter. Cash flows from operating activities were approximately $2.7 million during the September 2009 quarter. Deferred revenue and deferred profit balances at the end of the September 2009 quarter were $89.7 million and $55.6 million, respectively. Lam's deferred revenue balance does not include shipments to Japanese customers, to whom title does not transfer until customer acceptance. Shipments to Japanese customers are classified as inventory at cost until the time of acceptance. The anticipated future revenue from shipments to Japanese customers was approximately $23 million as of September 27, 2009.
"Lam Research had strong shipments and revenue performance in the September quarter, allowing the Company to return to profitability and generate positive cash flow once again. As business conditions improve, we continue our focus on developing leading-edge solutions for our customers while responding rapidly to meet their current production needs," said Steve Newberry, Lam's president and chief executive officer. "As we look forward to an improved business environment, we would like to thank our employees for their personal sacrifice during the downturn and their continued commitment to the success of Lam Research," Newberry concluded.
Statements made in this press release which are not statements of historical fact are forward-looking statements and are subject to the safe harbor provisions created by the Private Securities Litigation Reform Act of 1995. Such forward-looking statements relate, but are not limited, to the anticipated revenue from shipments to Japanese customers, Lam's focus on developing leading edge solutions while responding to customer production needs, and Lam's projections for future business conditions and an improved business environment. Some factors that may affect these forward-looking statements include: business conditions in the semiconductor industry and the overall economy, and the efficacy of Lam's plans for reacting to those conditions, changing customer demands, the actions of Lam's competitors, and the challenges presented by the development and marketing of new products. These forward-looking statements are based on current expectations and are subject to uncertainties and changes in condition, significance, value and effect as well as other risks detailed in documents filed with the Securities and Exchange Commission, including specifically the report on Form 10-K for the year ended June 28, 2009, which could cause actual results to vary from expectations. The Company undertakes no obligation to update the information or statements made in this press release.
Lam Research Corporation is a major provider of wafer fabrication equipment and services to the world's semiconductor industry. Lam's common stock trades on The NASDAQ Global Select Market SM under the symbol LRCX. Lam is a NASDAQ-100 (R) company. For more information, visit www.lamresearch.com.
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data and percentages)
(unaudited)
Three Months Ended
September 27, June 28, September 28,
2009 2009 2008
Total revenue $ 318,548 $ 217,764 $ 440,361
Cost of goods sold 187,233 150,007 254,203
Cost of goods sold - restructuring - - 3,048
and asset impairments
Cost of goods sold - 409A expense (5,455 ) - -
Total cost of goods sold 181,778 150,007 257,251
Gross margin 136,770 67,757 183,110
Gross margin as a percent of revenue 42.9 % 31.1 % 41.6 %
Research and development 71,199 67,491 81,563
Selling, general and administrative 52,119 47,248 68,299
Goodwill impairment - 7,179 -
Restructuring and asset impairments 2,093 5,396 15,968
409A expense (17,893 ) 982 761
Legal judgment - 4,647 -
Total operating expenses 107,518 132,943 166,591
Operating income (loss) 29,252 (65,186 ) 16,519
Operating margin as a percent of 9.2 % -29.9 % 3.8 %
revenue
Other income (expense), net (368 ) 2,869 9,017
Income (loss) before income taxes 28,884 (62,317 ) 25,536
Income tax expense 12,087 26,173 16,663
Net income (loss) $ 16,797 $ (88,490 ) $ 8,873
Net income (loss) per share:
Basic net income (loss) per share $ 0.13 $ (0.70 ) $ 0.07
Diluted net income (loss) per share $ 0.13 $ (0.70 ) $ 0.07
Number of shares used in per share
calculations:
Basic 126,774 126,273 125,527
Diluted 127,890 126,273 126,819
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands)
September 27, June 28,
2009 2009
(unaudited) (1)
ASSETS
Cash and cash equivalents $ 361,163 $ 374,167
Short-term investments 215,031 205,221
Accounts receivable, net 325,756 253,585
Inventories 220,083 233,410
Deferred income taxes 49,140 69,043
Other current assets 61,128 60,401
Total current assets 1,232,301 1,195,827
Property and equipment, net 211,348 215,666
Restricted cash and investments 185,010 178,439
Deferred income taxes 24,451 17,007
Goodwill and intangible assets 254,847 260,787
Other assets 87,148 84,145
Total assets $ 1,995,105 $ 1,951,871
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities $ 336,911 $ 340,763
Long-term debt and capital leases $ 35,787 $ 40,886
Income taxes payable 105,925 102,999
Other long-term liabilities 12,722 14,134
Stockholders' equity 1,503,760 1,453,089
Total liabilities and stockholders' equity $ 1,995,105 $ 1,951,871
1 Derived from audited financial statements
LAM RESEARCH CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(unaudited)
Three Months Ended
September 27, June 28, September 28,
2009 2009 2008
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income (loss) $ 16,797 $ (88,490 ) $ 8,873
Adjustments to reconcile net income
(loss) to net cash provided by (used
for) operating activities:
Depreciation and amortization 17,681 17,694 17,896
Deferred income taxes 12,482 19,913 (12,407 )
Equity-based compensation expense 13,958 13,358 15,408
Income tax benefit on equity-based (89 ) (1,173 ) 5,039
compensation plans
Excess tax benefit on equity-based (368 ) (237 ) (4,269 )
compensation plans
Goodwill impairment - 7,179 -
Restructuring and asset impairments 2,093 5,396 19,016
Other, net 1,159 2,535 2,665
Changes in operating asset accounts (61,009 ) (34,295 ) (9,089 )
Net cash provided by (used for) 2,704 (58,120 ) 43,132
operating activities
CASH FLOWS FROM INVESTING ACTIVITIES:
Capital expenditures and intangible (5,832 ) (5,848 ) (15,151 )
assets
Acquisitions of businesses, net of - - (2,427 )
cash acquired
Net sales (purchases) of (9,775 ) 93,056 6,980
available-for-sale securities
Purchase of other investments (961 ) - -
Transfer of restricted cash and (6,571 ) (44,458 ) (16,128 )
investments
Other - 2,000 -
Net cash provided by (used for) (23,139 ) 44,750 (26,726 )
investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Principal payments on long-term debt (1,915 ) (911 ) (2,390 )
and capital lease obligations
Net proceeds from issuance of 284 - 127
long-term debt
Excess tax benefit on equity-based 368 237 4,269
compensation plans
Treasury stock purchases (2,356 ) (3,197 ) (2,755 )
Reissuances of treasury stock 5,761 6,271 7,584
Proceeds from issuance of common 2,256 6,287 3,150
stock
Net cash provided by financing 4,398 8,687 9,985
activities
Effect of exchange rate changes on 3,033 4,202 (13,496 )
cash
Net increase (decrease) in cash and (13,004 ) (481 ) 12,895
cash equivalents
Cash and cash equivalents at 374,167 374,648 732,537
beginning of period
Cash and cash equivalents at end of $ 361,163 $ 374,167 $ 745,432
period
Reconciliation of U.S. GAAP Net Income (Loss) to Ongoing Net Income (Loss)
(in thousands, except per share data)
(unaudited)
Three Months Ended Three Months Ended
September 27, June 28,
2009 2009
U.S. GAAP net income (loss) $ 16,797 $ (88,490 )
Pre-tax non-ongoing items:
Goodwill impairment - operating expenses - 7,179
Legal judgment - operating expenses - 4,647
Restructuring and asset impairments - 2,093 5,396
operating expenses
409A expense - cost of goods sold (5,455 ) -
409A expense - operating expenses (17,893 ) 982
One-time contract termination costs - - 413
operating expenses
Net tax expense (benefit) on non-ongoing 8,639 (4,556 )
items
Net tax expense on resolution of certain - 3,637
tax matters
Net tax expense for valuation allowance - 13,787
Ongoing net income (loss) $ 4,181 $ (57,005 )
Ongoing net income (loss) per diluted $ 0.03 $ (0.45 )
share
Number of shares used for diluted per 127,890 126,273
share calculation
Reconciliation of U.S. GAAP Gross Margin, Operating Expenses and Operating
Income (Loss) to Ongoing Gross Margin, Operating Expenses and Operating Income
(Loss)
(in thousands, except percentages)
(unaudited)
Three Months Ended Three Months Ended
September 27, June 28,
2009 2009
U.S. GAAP gross margin $ 136,770 $ 67,757
Pre-tax non-ongoing items:
Pre-tax 409A expense - cost of goods (5,455 ) -
sold
Ongoing gross margin $ 131,315 $ 67,757
U.S. GAAP gross margin as a percent of 42.9 % 31.1 %
revenue
Ongoing gross margin as a percent of 41.2 % 31.1 %
revenue
U.S. GAAP operating expenses $ 107,518 $ 132,943
Pre-tax non-ongoing items:
Goodwill impairment - operating expenses - (7,179 )
Legal judgment - operating expenses - (4,647 )
Restructuring and asset impairments - (2,093 ) (5,396 )
operating expenses
One-time contract termination costs - - (413 )
operating expenses
409A expense - operating expenses 17,893 (982 )
Ongoing operating expenses $ 123,318 $ 114,326
Ongoing operating income (loss) $ 7,997 $ (46,569 )
Ongoing operating margin as a percent of 2.5 % -21.4 %
revenue
Source: Lam Research Corporation
Related Categories
Press ReleasesStocks Mentioned
-0.46Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
